Position in DNA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$240,922
+$115,251 QoQ
Shares Held
24,311
+18.6% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 183 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026IMC-Chicago, LLC holds $54,107,382 across 30 Biotechnology names. DNA ranks #24 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
87,392 | $11,645,857 | |
| 2 | INSM |
INSMED Inc
|
76,126 | $8,116,554 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,847 | $5,824,296 | |
| 4 | CELC |
Celcuity Inc.
|
41,127 | $4,302,706 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,591 | $3,486,212 | |
| 6 | BNTX |
BioNTech SE
|
29,282 | $2,724,690 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
10,187 | $2,493,471 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
68,630 | $2,428,815 |
All Filings in DNA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $240,922 | 24,311 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $125,671 | 20,501 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||